Does genetic variation in the Δ6-desaturase promoter modify the association between α-linolenic acid and the prevalence of metabolic syndrome?
Wedi'i Gadw mewn:
| Awduron: | , , , , , |
|---|---|
| Fformat: | artículo original |
| Dyddiad Cyhoeddi: | 2009 |
| Disgrifiad: | Background: Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are associated with protection against components of the metabolic syndrome, but the role of α-linolenic acid (ALA), the metabolic precursor of EPA and DHA, has not been studied. The Δ6-desaturase enzyme converts ALA into EPA and DHA, and genetic variation in the Δ6-desaturase gene (FADS2) may affect this conversion. |
| Gwlad: | Kérwá |
| Sefydliad: | Universidad de Costa Rica |
| Repositorio: | Kérwá |
| OAI Identifier: | oai:kerwa.ucr.ac.cr:10669/81221 |
| Mynediad Ar-lein: | https://academic.oup.com/ajcn/article/89/3/920/4596766?searchresult=1 https://hdl.handle.net/10669/81221 |
| Allweddair: | Enfermedades cardiovasculares Metabolismo |